FLEXION THERAPEUTICS INC - COM (FLXN)

CUSIP: 33938J106

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
50,176,793
Share change
+246,724
Total reported value
$579,029,742
Put/Call ratio
286%
Price per share
$11.54
Number of holders
136
Value change
+$4,315,089
Number of buys
63
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q4 2020

As of 31 Dec 2020, FLEXION THERAPEUTICS INC - COM (FLXN) was held by 136 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 50,176,793 shares. The largest 10 holders included BlackRock Inc., MILLER VALUE PARTNERS, LLC, WASATCH ADVISORS INC, Versant Venture Management, LLC, Capital World Investors, Artisan Partners Limited Partnership, STATE STREET CORP, VANGUARD GROUP INC, ORBIMED ADVISORS LLC, and Novo Holdings A/S. This page lists 136 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.